An Evaluation of Hepatitis B Virus and Hepatitis C Virus Frequency and the Anti-hepatitis B Surface Seropositivity of Syrian Refugees in the Karabük Province
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 3
Abstract
Objectives: To investigate the frequency of hepatitis B Virus (HBV) and HCV with anti- hepatitis B Surface (HBs) seropositivity using serological and molecular methods in Syrian refugees in the Karabük. Materials and Methods: The study included the HBs Antigen (HBsAg), anti-HBs, anti-HCV, HCV-RNA, HBV-DNA, and HCV genotyping results of Syrian refugees who presented at the Karabük University Training and Research Hospital between January 2016 and March 2019. Results: The 809 patients were comprised of 536 (66.3%) females and 273 (33.7%) males with a mean age of 34 years. HBsAg was found to be positive in 2.3% of patients and in all HBV-DNA were positive. The anti-HBs seropositivity rate was determined as 21.6% and a significant difference was determined between age groups (p=0.001). The anti-HCV was positive in 8 (1%) patients and the HCV-RNA viral load was determined in 7/8. In these 7 patients, the HCV genotype was determined as genotype 1b in 3, genotype 3 in 2, and genotype 4 in 2. Conclusion: This study showed that while the frequency of HBV and HCV in Syrian refugees was similar to the data for Turkey, anti-HBs seropositivity was extremely low. Hepatitis B vaccination programs for Syrian refugees should be implemented and regularly followed up.
Authors and Affiliations
Nergis Aşgın, Şerife Satılmış
Keywords
Related Articles
- EP ID EP676543
- DOI 10.4274/vhd.galenos.2019.2019.0033
- Views 178
- Downloads 0
Investigating the Prevalence of Hepatitis Delta and Assessment of Treatment Response
Objectives: The purpose of this study was to investigate the seroprevalence of delta virus, assess the treatment outcomes of patients receiving treatment. Materials and Methods: The files of patients diagnosed with chro...
Relationship Between Viral Load and Prohepcidin Levels in Chronic Hepatitis B Patients
No summary
Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection
Objectives: Literature data concerning the outcomes of direct acting antiviral (DAA) therapy in mixed genotype hepatitis C virus (HCV) infections are very limited, and the incidence of mixed HCV infection in Turkey is un...
Age Specific Hepatitis B Surface Antigen (HBsAg) and Anti-HBs Seroprevalence among Patients Admitted to a State Hospital
Objectives: Chronic hepatitis B (CHB) infection affects 257 million people globally, Turkey is middle endemic region. According to public health data, about 2 million people in Turkey are considered to be positive for he...
Effect of Advanced Fibrosis Presence on Adherence to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients with Sustained Virologic Response
Objectives: Although hepatocellular carcinoma (HCC) screening is accepted as standard care in patients with chronic hepatitis C (CHC) diagnosis, sustained viral response (SVR) has been obtained by treatment and it is not...